Cure My Disease

Don't miss your cure!

 Log in / Sign up

Exercise and naps may boost brain training in MS patients

NCT ID NCT07304375

Recruiting now Knowledge-focused Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a short burst of aerobic exercise on a stationary bike and a 30-minute nap can improve how people with multiple sclerosis learn and remember a hand motor skill. Twenty adults with relapsing-remitting MS will take part. Researchers will measure brain and muscle activity to see if these simple interventions enhance motor rehabilitation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
aerobic exercise and daytime nap
What this could lead to
If it works, this could point toward simple, drug-free ways to boost motor rehabilitation in people with MS.
What could go wrong
This is a very small, early-stage study with only 20 participants. It looks at short-term effects, so any benefits may not last or apply to everyone with MS.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXERCISE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity multiple sclerosis relapsing-remitting multiple sclerosis sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXERCISE MEMORY MOTOR LEARNING MULTIPLE SCLEROSIS SLEEP

Contacts and locations

Locations

  • Section of Movement and Neuroscience, Department of Nutrition, Exercise, and Sports, University of Copenhagen

    NOT_YET_RECRUITING

    Copenhagen, 2200, Denmark

  • Zealand University Hospital Roskilde

    RECRUITING

    Roskilde, 4000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.